LDL-Cholesterol Assay
- UID
- IMP/IVD/2021/000511_3357024e3704d0ee069c98d982a4c151_abc1cf9af426d24211432c4d3341d9cb
- Device class
- Class B
- Brand name
- Adenosine Deaminase Assay
- License holder
- TRANSASIA BIO-MEDICALS LIMITED
- Approving authority
- CDSCO
- Product information
- The Diazyme LDL-Cholesterol Assay is intended for the in vitro quantitative determination of Low Density Lipoprotein Cholesterol in human serum or plasma. The reagents can assist in the diagnosis and treatment of patients at risk of developing coronary heart disease
LDL-Cholesterol Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000511_3357024e3704d0ee069c98d982a4c151_abc1cf9af426d24211432c4d3341d9cb. This device is marketed under the brand name Adenosine Deaminase Assay. The license holder is TRANSASIA BIO-MEDICALS LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.